- Trials with a EudraCT protocol (43)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
43 result(s) found for: Cannabis.
Displaying page 1 of 3.
EudraCT Number: 2014-002977-12 | Sponsor Protocol Number: EPUP81 | Start Date*: 2014-10-08 |
Sponsor Name:Maastriccht University | ||
Full Title: BRAIN KINETICS OF NEUROTRANSMISSION DURING THC INTOXICATION | ||
Medical condition: Brain functioning during THC intoxication | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-000766-23 | Sponsor Protocol Number: D1443C00018 | Start Date*: 2008-12-22 |
Sponsor Name:Medical School Hannover, Department of Psychiatry, Socialpsychiatry and Psychotherapy | ||
Full Title: Effects of QuetiapineXR in schizophrenic patients with cannabis abuse and/or cannabis induced psychosis -pilot study- | ||
Medical condition: cannabis induced psychosis/schizophrenic patients with cannabis abuse | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-005263-29 | Sponsor Protocol Number: 25-01 | Start Date*: 2006-01-31 |
Sponsor Name:Gesellschaft fuer klinische Forschung e.V. (Society for Clinical Research)
[...]
1. Gesellschaft fuer klinische Forschung e.V. (Society for Clinical Research)
2. WELEDA AG |
||
Full Title: Multiple Sclerosis and Extract of Cannabis (MUSEC): A randomised, double-blind, placebo-controlled phase III trial to determine the efficacy and safety of a standardised oral extract of Cannabis sa... | ||
Medical condition: Multiple Sclerosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-000305-24 | Sponsor Protocol Number: AN01AC11 | Start Date*: 2021-03-18 |
Sponsor Name:Anebulo pharmaceuticals, Inc. | ||
Full Title: A randomized, double-blind, placebo-controlled study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single oral doses of CB1 antagonist ANEB-001 in healthy occasional ... | ||
Medical condition: THC intoxication | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-005198-38 | Sponsor Protocol Number: CANNA1 | Start Date*: 2018-10-26 | |||||||||||
Sponsor Name:Odense University Hospital | |||||||||||||
Full Title: Tetra-hydro-cannabinol, cannabidiol and their combination for the treatment of peripheral neuropathic pain. A randomised placebo-controlled trial. | |||||||||||||
Medical condition: Peripheral neuropathic pain due to polyneuropathy, postherpetic neuralgia, or peripheral nerve injury (surgical or traumatic). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002315-98 | Sponsor Protocol Number: MedicalcannabisMSSCI2018 | Start Date*: 2018-12-06 | ||||||||||||||||
Sponsor Name:Aarhus Universitetshospital | ||||||||||||||||||
Full Title: The effect of medical cannabis on neuropathic pain and spasticity in patients with Multiple Sclerosis and in patients with spinal cord injury. A multicenter national placebo-controlled trial | ||||||||||||||||||
Medical condition: Central neuropathic pain and spasticity | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2021-000083-29 | Sponsor Protocol Number: P21.xxx | Start Date*: 2021-07-13 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: Influence of ∆9-tetrahydrocannabinol (THC) on oxycodone induced ventilatory depression in healthy volunteers | ||
Medical condition: healthy volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002394-59 | Sponsor Protocol Number: P142 | Start Date*: 2020-11-30 | |||||||||||
Sponsor Name:The Parker Institute, Bispebjerg and Frederiksberg Hospital | |||||||||||||
Full Title: Medical Cannabis for fibromyalgia - The CANNFIB trial Protocol for a randomized, double-blind, placebo-controlled, parallelgroup, single-center trial | |||||||||||||
Medical condition: Fibromyalgia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-000393-47 | Sponsor Protocol Number: SP000680 | Start Date*: 2004-09-22 | |||||||||||
Sponsor Name:AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA | |||||||||||||
Full Title: Effect of Cannabis Based Medicine Extract Sativex on brain function as assessed by fMRI and neurophysiologic evaluation in patients with Multiple Sclerosis a double blind, randomised, placebo-co... | |||||||||||||
Medical condition: Treatment of spasticity in patients with Multiple Sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000420-15 | Sponsor Protocol Number: AKF1919 | Start Date*: 2016-03-24 | |||||||||||
Sponsor Name:Radboud University Medical Centre, department of Psychiatry | |||||||||||||
Full Title: Slow continuous subcutaneous flumazenil infusion for benzodiazepine dependence: a pilot study | |||||||||||||
Medical condition: Patients diagnosed with benzodiazepine dependence with an average daily dose of at least 30 mg of diazepam equivalence. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001861-33 | Sponsor Protocol Number: P19.050 | Start Date*: 2019-07-17 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: Cannabis-opioid interaction in the treatment of fibromyalgia pain – an open label proof-of-concept study | ||
Medical condition: Chronic fibromyalgia pain | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-022808-40 | Sponsor Protocol Number: CANALS | Start Date*: 2011-01-13 | |||||||||||
Sponsor Name:FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR | |||||||||||||
Full Title: A fase II, randomized, Double-Blind, Placebo-Controlled, Multicentre Study for the Safety and Efficacy on Spasticity Symptoms of a Cannabis Sativa Extract in Motor Neuron Disease Patients | |||||||||||||
Medical condition: amyotrophic lateral sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003574-13 | Sponsor Protocol Number: 020683 | Start Date*: 2018-03-08 | ||||||||||||||||
Sponsor Name:Aalborg university hospital dept. of rheumatology | ||||||||||||||||||
Full Title: The NordCAN study: Cannabis treatment in hand osteoarthritis and psoriatic arthritis. A randomized, double-blind placebo controlled study | ||||||||||||||||||
Medical condition: Psoriatic Arthritis Hand Osteoarthritis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-000564-42 | Sponsor Protocol Number: CANNA-TICS | Start Date*: 2017-06-14 | ||||||||||||||||
Sponsor Name:Hannover Medical School | ||||||||||||||||||
Full Title: A randomized multi-centre double-blind placebo controlled trial to demonstrate the efficacy and safety of nabiximols in the treatment of adults with chronic tic disorders (CANNA-TICS) | ||||||||||||||||||
Medical condition: Chronic tic disorders and Tourette syndrome | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-002728-33 | Sponsor Protocol Number: CUPID2005 | Start Date*: 2006-02-28 |
Sponsor Name:Plymouth Hospitals NHS Trust | ||
Full Title: Cannabinoid Use in Progressive Inflammatory brain Disease | ||
Medical condition: Progressive multiple sclerosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-005344-17 | Sponsor Protocol Number: CBDV_2014 | Start Date*: 2015-08-21 |
Sponsor Name:Department of Anesthesiology and Operative Intensive Care Medicine, Charité (CBF) | ||
Full Title: Oral cannabidivarin (CBDV) solution for treatment of HIV-associated neuropathic pain – a randomized, double-blind, placebo-controlled phase II study. | ||
Medical condition: Chronic painful HIV-associated neuropathy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-006236-63 | Sponsor Protocol Number: EVT 302/3011 | Start Date*: 2008-01-23 | |||||||||||
Sponsor Name:Evotec Neurosciences GmbH | |||||||||||||
Full Title: A double-blind, randomized, placebo- and NRT-controlled Phase II study to assess the effects of EVT 302 alone and in combination with NRT on craving and withdrawal in healthy male smokers deprived ... | |||||||||||||
Medical condition: Smoking cessation. Assessment of the effect of EVT 302 alone or in combination with a nicotine replacement therapy (NRT) on craving and withdrawal in smokers after short-term deprivation of cigare... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-001358-41 | Sponsor Protocol Number: VERCLBP002 | Start Date*: 2023-02-27 |
Sponsor Name:Vertanical GmbH | ||
Full Title: Multicentre, randomized, open-label study to prove an additional benefit of the full-spectrum cannabis extract VER-01 over opioids in the treatment of patients with chronic non-specific low back pain. | ||
Medical condition: Chronic non-specific low back pain | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) ES (Temporarily Halted) CZ (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-016065-29 | Sponsor Protocol Number: GWCA0962 | Start Date*: 2010-03-10 | |||||||||||
Sponsor Name:GW Pharma Ltd. | |||||||||||||
Full Title: A double blind, randomized, placebo-controlled, parallel group study of Sativex oromucosal spray (Sativex®; Nabiximols) as adjunctive therapy in relieving uncontrolled persistent chronic pain in pa... | |||||||||||||
Medical condition: Pain in patients with advanced cancer, who experience inadequate analgesia during optimized chronic opioid therapy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) GB (Completed) DE (Completed) PL (Completed) BG (Completed) HU (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-001834-27 | Sponsor Protocol Number: GWEP1415 | Start Date*: 2015-01-14 | |||||||||||
Sponsor Name:GW Research Ltd | |||||||||||||
Full Title: An open label extension study to investigate the safety of cannabidiol (GWP42003-P; CBD) in children and adults with inadequately controlled Dravet or Lennox-Gastaut Syndromes | |||||||||||||
Medical condition: Dravet Syndrome (DS) or Lennox-Gastaut Syndrome (LGS) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Completed) PL (Completed) NL (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
